Search research articles
Contact Us
Filters
Showing results (11-20 of 15) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 15 results.
Plos Pathogens
|
July 21, 2022
Structure-selected RBM immunogens prime polyclonal memory responses that neutralize SARS-CoV-2 variants of concern
Gonzalo Almanza, Alex E Clark, Valentina Kouznetsova, et al.
Mbio
|
November 17, 2025
Interferon-inducible guanylate-binding protein 5 inhibits replication of multiple viruses by binding to the oligosaccharyltransferase complex and inhibiting glycoprotein maturation
Shaobo Wang, Wanyu Li, Jing Wen, et al.
Plos Pathogens
|
November 25, 2025
Correction: Structure-selected RBM immunogens prime polyclonal memory responses that neutralize SARS-CoV-2 variants of concern
Gonzalo Almanza, Alex E Clark, Valentina Kouznetsova, et al.
The Journal of Infectious Diseases
|
December 16, 2024
Antibody Levels From High-Throughput Variant-Specific SARS-CoV-2 Anti-Spike Immunoglobulin G and Angiotensin-Converting Enzyme 2 Neutralization Assays Correlate With COVID-19 Infection Risk in a Large Population
Marni B Jacobs, Alex E Clark, Nicole H Goldhaber, et al.
Journal of Medicinal Chemistry
|
April 11, 2023
1-<i>O</i>-Octadecyl-2-<i>O</i>-benzyl-<i>sn</i>-glyceryl-3-<i>phospho</i>-GS-441524 (V2043). Evaluation of Oral V2043 in a Mouse Model of SARS-CoV-2 Infection and Synthesis and Antiviral Evaluation of Additional Phospholipid Esters with Enhanced Anti-SARS-CoV-2 Activity
Aaron F Carlin, James R Beadle, Alex E Clark, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 15) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 15 results.
Plos Pathogens
|
July 21, 2022
Structure-selected RBM immunogens prime polyclonal memory responses that neutralize SARS-CoV-2 variants of concern
Gonzalo Almanza, Alex E Clark, Valentina Kouznetsova, et al.
Mbio
|
November 17, 2025
Interferon-inducible guanylate-binding protein 5 inhibits replication of multiple viruses by binding to the oligosaccharyltransferase complex and inhibiting glycoprotein maturation
Shaobo Wang, Wanyu Li, Jing Wen, et al.
Plos Pathogens
|
November 25, 2025
Correction: Structure-selected RBM immunogens prime polyclonal memory responses that neutralize SARS-CoV-2 variants of concern
Gonzalo Almanza, Alex E Clark, Valentina Kouznetsova, et al.
The Journal of Infectious Diseases
|
December 16, 2024
Antibody Levels From High-Throughput Variant-Specific SARS-CoV-2 Anti-Spike Immunoglobulin G and Angiotensin-Converting Enzyme 2 Neutralization Assays Correlate With COVID-19 Infection Risk in a Large Population
Marni B Jacobs, Alex E Clark, Nicole H Goldhaber, et al.
Journal of Medicinal Chemistry
|
April 11, 2023
1-<i>O</i>-Octadecyl-2-<i>O</i>-benzyl-<i>sn</i>-glyceryl-3-<i>phospho</i>-GS-441524 (V2043). Evaluation of Oral V2043 in a Mouse Model of SARS-CoV-2 Infection and Synthesis and Antiviral Evaluation of Additional Phospholipid Esters with Enhanced Anti-SARS-CoV-2 Activity
Aaron F Carlin, James R Beadle, Alex E Clark, et al.
Page
of 2